仪器网
产品库
BFH772 is a potent oral VEGFR2 inhibitor, which is highly effective at targeting VEGFR2 kinase with anIC50 value of 3 nM.
BFH772 is a potent oral VEGFR2 inhibitor, which is highly effective at targeting VEGFR2 kinase with anIC50 value of 3 nM.
Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.
VEGFR2、VEGFR2基因、VEGFR2 cDNA克隆、VEGFR2 ORF克隆
Lymphatic-targeting/Tumor-targeting/Liver-targeting/Inflammation-targeting Nanoparticles(SunLipo NanoTech)
15 – 13,000,000 lb effective weights available 上海航欧销售美国减震器.
Normag(TM) macro vigreux column effective L 300 mm
Aldrich(R) Vigreux column Vacuum-jacketed, effective L 300 mm
Aldrich(R) Hempel column Vacuum-jacketed, effective L 300 mm, O.D. x I.D. 38 mm x 19 mm
Aldrich(R) Micro Vigreux column Unjacketed, effective L 190 mm
Aldrich(R) Vigreux column Unjacketed, effective L 150 mm
Aldrich(R) Vigreux column Unjacketed, effective L 300 mm
Aldrich(R) Vigreux column Vacuum-jacketed, effective L 75 mm
本产品信息由（厦门慧嘉生物科技有限公司）为您提供，内容包括（BFH772 is a potent oral VEGFR2 inhibitor, which is highly effective at targeting VEGFR2 kinase with anIC50 value of 3 nM.）的品牌、型号、技术参数、详细介绍等；如果您想了解更多关于（BFH772 is a potent oral VEGFR2 inhibitor, which is highly effective at targeting VEGFR2 kinase with anIC50 value of 3 nM.）的信息，请直接联系供应商，给供应商留言。若当前页面内容侵犯到您的权益，请及时告知我们，我们将马上修改或删除。
沪公网安备 31011502008050号
